Trials / Completed
CompletedNCT05702489
A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 900 (actual)
- Sponsor
- Nanjing Zenshine Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to compare ZX-7101A in Chinese Adults patients with uncomplicated influenza. The main questions it aims to answer are: * The efficacy of ZX-7101A in Chinese Adults patients with uncomplicated influenza. * The safety of ZX-7101A in Chinese Adults patients with uncomplicated influenza.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZX-7101A | a drug to treatment influenza in Chinese adults |
Timeline
- Start date
- 2022-07-17
- Primary completion
- 2023-05-26
- Completion
- 2023-10-13
- First posted
- 2023-01-27
- Last updated
- 2024-11-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05702489. Inclusion in this directory is not an endorsement.